Product Overview

Developing therapies for Multiple Sclerosis (MS) will require understanding the genetic and biological drivers of progressive MS, including primary progressive (PPMS) and secondary progressive subtypes (SPMS).

We are building a large MS cohort with detailed longitudinal and subtype data to compare progressive MS to relapsing remitting MS of long duration, vs controls, and are inviting partners to join.



Other Available Disease Cohorts

View All Our Cohorts
  • Oncology
  • Liver Disease
  • Cardiovascular
  • Neurology & Pain
  • Immunology & Rheumatology
  • Diabetes & Complications
  • Respiratory
  • Ophthalmology
  • Dermatology